Secondary Logo

Most Popular Articles

Living donor liver transplant from an HIV-positive mother to her HIV-negative child: opening up new therapeutic options

Botha, Jean; Conradie, Francesca; Etheredge, Harriet; More

AIDS. 32(16):F13-F19, October 23, 2018.

Young people's sexual health in South Africa: HIV prevalence and sexual behaviors from a nationally representative household survey

Pettifor, Audrey E; Rees, Helen V; Kleinschmidt, Immo; More

AIDS. 19(14):1525-1534, September 23rd, 2005.

Cardiovascular disease risk factors in HIV patients – association with antiretroviral therapy. Results from the DAD study

Friis-Møller, Nina; Weber, Rainer; Reiss, Peter; More

AIDS. 17(8):1179-1193, May 23rd, 2003.

Dynamics of HIV viremia and antibody seroconversion in plasma donors: implications for diagnosis and staging of primary HIV infection

Fiebig, Eberhard W; Wright, David J; Rawal, Bhupat D; More

AIDS. 17(13):1871-1879, September 5th, 2003.

Hepatitis B and HIV: prevalence, AIDS progression, response to highly active antiretroviral therapy and increased mortality in the EuroSIDA cohort

Konopnicki, Deborah; Mocroft, Amanda; de Wit, S; More

AIDS. 19(6):593-601, April 8th, 2005.

HLA-associated polymorphisms in the HIV-2 capsid highlight key differences between HIV-1 and HIV-2 immune adaptation

de Silva, Thushan I.; Leligdowicz, Aleksandra; Carlson, Jonathan; More

AIDS. 32(6):709-714, March 27, 2018.

Monotypic low-level HIV viremias during antiretroviral therapy are associated with disproportionate production of X4 virions and systemic immune activation

Bull, Marta E.; Mitchell, Caroline; Soria, Jaime; More

AIDS. 32(11):1389-1401, July 17, 2018.

Do prevention interventions reduce HIV risk behaviours among people living with HIV? A meta-analytic review of controlled trials

Crepaz, Nicole; Lyles, Cynthia M; Wolitski, Richard J; More

AIDS. 20(2):143-157, January 9th, 2006.

A week-48 randomized phase-3 trial of darunavir/cobicistat/emtricitabine/tenofovir alafenamide in treatment-naive HIV-1 patients

Eron, Joseph J.; Orkin, Chloe; Gallant, Joel; More

AIDS. 32(11):1431-1442, July 17, 2018.

Phase I clinical trial of an intranodally administered mRNA-based therapeutic vaccine against HIV-1 infection

Leal, Lorna; Guardo, Alberto C.; Morón-López, Sara; More

AIDS. 32(17):2533-2545, November 13, 2018.

Noncommunicable diseases among HIV-infected persons in low-income and middle-income countries: a systematic review and meta-analysis

Patel, Pragna; Rose, Charles E.; Collins, Pamela Y.; More

AIDS. 32:S5-S20, July 1, 2018.

Changes in sexual behavior and risk of HIV transmission after antiretroviral therapy and prevention interventions in rural Uganda

Bunnell, Rebecca; Ekwaru, John Paul; Solberg, Peter; More

AIDS. 20(1):85-92, January 2nd, 2006.

Cognitive dysfunction in HIV patients despite long-standing suppression of viremia

Simioni, Samanta; Cavassini, Matthias; Annoni, Jean-Marie; More

AIDS. 24(9):1243-1250, June 1st, 2010.

Validation of a simplified medication adherence questionnaire in a large cohort of HIV-infected patients: the GEEMA Study

Knobel, Hernando; Alonso, Jordi; Casado, José L.; More

AIDS. 16(4):605-613, March 8th, 2002.

Cumulative exposure to nucleoside analogue reverse transcriptase inhibitors is associated with insulin resistance markers in the Multicenter AIDS Cohort Study

Brown, Todd T; Li, Xiuhong; Cole, Stephen R; More

AIDS. 19(13):1375-1383, September 2nd, 2005.

HIV incidence and sexually transmitted disease prevalence associated with condom use: a population study in Rakai, Uganda

Ahmed, Saifuddin; Lutalo, Tom; Wawer, Maria; More

AIDS. 15(16):2171-2179, November 9th, 2001.

Explosive spread and high prevalence of HIV infection among injecting drug users in Togliatti City, Russia

Rhodes, Tim; Lowndes, Catherine; Judd, Ali; More

AIDS. 16(13):F25-F31, September 6th, 2002.

Show: